These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32542913)

  • 1. An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells.
    Kerr SC; Gonzalez JR; Schanin J; Peters MC; Lambrecht BN; Brock EC; Charbit A; Ansel KM; Youngblood BA; Fahy JV
    Clin Exp Allergy; 2020 Aug; 50(8):904-914. PubMed ID: 32542913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice.
    Youngblood BA; Brock EC; Leung J; Falahati R; Bryce PJ; Bright J; Williams J; Shultz LD; Greiner DL; Brehm MA; Bebbington C; Tomasevic N
    Int Arch Allergy Immunol; 2019; 180(2):91-102. PubMed ID: 31401630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.
    Gebremeskel S; Schanin J; Coyle KM; Butuci M; Luu T; Brock EC; Xu A; Wong A; Leung J; Korver W; Morin RD; Schleimer RP; Bochner BS; Youngblood BA
    Front Immunol; 2021; 12():650331. PubMed ID: 33777047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
    Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
    J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression.
    Hudson SA; Herrmann H; Du J; Cox P; Haddad el-B; Butler B; Crocker PR; Ackerman SJ; Valent P; Bochner BS
    J Clin Immunol; 2011 Dec; 31(6):1045-53. PubMed ID: 21938510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery, Function, and Therapeutic Targeting of Siglec-8.
    Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
    Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement.
    Yokoi H; Choi OH; Hubbard W; Lee HS; Canning BJ; Lee HH; Ryu SD; von Gunten S; Bickel CA; Hudson SA; Macglashan DW; Bochner BS
    J Allergy Clin Immunol; 2008 Feb; 121(2):499-505.e1. PubMed ID: 18036650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge.
    Johansson MW; Kelly EA; Nguyen CL; Jarjour NN; Bochner BS
    Int Arch Allergy Immunol; 2018; 177(1):16-28. PubMed ID: 29879704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siglec-8 and Siglec-F, the new therapeutic targets in asthma.
    Farid SSh; Mirshafiey A; Razavi A
    Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):721-6. PubMed ID: 22324980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells.
    O'Sullivan JA; Carroll DJ; Cao Y; Salicru AN; Bochner BS
    J Allergy Clin Immunol; 2018 May; 141(5):1774-1785.e7. PubMed ID: 28734845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis.
    Youngblood BA; Brock EC; Leung J; Falahati R; Bochner BS; Rasmussen HS; Peterson K; Bebbington C; Tomasevic N
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
    Bochner BS
    Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI-Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen Challenge.
    Duan S; Arlian BM; Nycholat CM; Wei Y; Tateno H; Smith SA; Macauley MS; Zhu Z; Bochner BS; Paulson JC
    J Immunol; 2021 May; 206(10):2290-2300. PubMed ID: 33911007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice.
    Wei Y; Chhiba KD; Zhang F; Ye X; Wang L; Zhang L; Robida PA; Moreno-Vinasco L; Schnaar RL; Roers A; Hartmann K; Lee CM; Demers D; Zheng T; Bochner BS; Zhu Z
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.
    Kiwamoto T; Kawasaki N; Paulson JC; Bochner BS
    Pharmacol Ther; 2012 Sep; 135(3):327-36. PubMed ID: 22749793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils.
    O'Sullivan JA; Wei Y; Carroll DJ; Moreno-Vinasco L; Cao Y; Zhang F; Lee JJ; Zhu Z; Bochner BS
    J Leukoc Biol; 2018 Jul; 104(1):11-19. PubMed ID: 29601103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activation.
    Kano G; Almanan M; Bochner BS; Zimmermann N
    J Allergy Clin Immunol; 2013 Aug; 132(2):437-45. PubMed ID: 23684072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation.
    Schanin J; Gebremeskel S; Korver W; Falahati R; Butuci M; Haw TJ; Nair PM; Liu G; Hansbro NG; Hansbro PM; Evensen E; Brock EC; Xu A; Wong A; Leung J; Bebbington C; Tomasevic N; Youngblood BA
    Mucosal Immunol; 2021 Mar; 14(2):366-376. PubMed ID: 32814824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Siglec"ting the allergic response for therapeutic targeting.
    Bochner BS
    Glycobiology; 2016 Jun; 26(6):546-52. PubMed ID: 26911285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β
    Carroll DJ; O'Sullivan JA; Nix DB; Cao Y; Tiemeyer M; Bochner BS
    J Allergy Clin Immunol; 2018 Jun; 141(6):2196-2207. PubMed ID: 28888781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.